Assessing Benefits in Clinical Research: Why Diversity in Benefit Assessment Can Be Risky

, , , , , &
IRB: Ethics & Human Research 25 (3):1 (2003)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.2307/3564297

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The social value of clinical research.Michelle Gjl Habets, Johannes Jm van Delden & AnneLien L. Bredenoord - 2014 - BMC Medical Ethics 15 (1):66.
Consent forms and the therapeutic misconception.Nancy M. P. King, Gail E. Henderson, Larry R. Churchill, Arlene M. Davis, Sara Chandros Hull, Daniel K. Nelson, P. Christy Parham-Vetter, Barbra Bluestone Rothschild, Michele M. Easter & Benjamin S. Wilfond - 2005 - IRB: Ethics & Human Research 27 (1):1-7.
Understanding risks and benefits in research on reproductive genetic technologies.Janet Malek - 2007 - Journal of Medicine and Philosophy 32 (4):339 – 358.
The Social Value of Knowledge and International Clinical Research.Danielle M. Wenner - 2013 - Developing World Bioethics 15 (2):76-84.
Benefit Sharing in a Global Context: Working Towards Solutions for Implementation.Daniel J. Hurst - 2016 - Developing World Bioethics 17 (2):70-76.
Research biopsies in phase I studies: views and perspectives of participants and investigators.R. D. Pentz, R. D. Harvey, M. White, Z. L. Farmer, O. Dashevskaya, Z. Chen, C. Lewis, T. K. Owonikoko & F. R. Khuri - 2012 - IRB: Ethics & Human Research 34 (2):1-8.
Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands.H. van Luijn, A. Musschenga, R. Keus & N. Aaronson - 2007 - IRB: Ethics & Human Research 29 (1).
A New Justification for Pediatric Research Without the Potential for Clinical Benefit.David Wendler - 2012 - American Journal of Bioethics 12 (1):23 - 31.
Benefits to research subjects in international trials: Do they reduce exploitation or increase undue inducement?Angela Ballantyne - 2006 - Developing World Bioethics 8 (3):178-191.
Participants' perceptions of research benefits in an african genetic epidemiology study.John Appiah-Poku, Sam Newton & Nancy Kass - 2011 - Developing World Bioethics 11 (3):128-135.
Assessing Diversity: June Boyce-Tillman.King Alfred’S. - 2003 - Arts and Humanities in Higher Education 2 (1):41-62.
Assessing research risks systematically: the net risks test.D. Wendler & F. G. Miller - 2007 - Journal of Medical Ethics 33 (8):481-486.
The placebo phenomenon and medical ethics: Rethinking the relationship between informed consent and risk–benefit assessment.Franklin G. Miller & Luana Colloca - 2011 - Theoretical Medicine and Bioethics 32 (4):229-243.
The Merits of Procedure-Level Risk-Benefit Assessment.Anna Westra & Inez de Beaufort - 2011 - IRB: Ethics & Human Research 33 (5):7-13.
Ethics and epistemology of accurate prediction in clinical research.Spencer Phillips Hey - 2015 - Journal of Medical Ethics 41 (7):559-562.

Analytics

Added to PP
2021-04-28

Downloads
11 (#1,075,532)

6 months
6 (#431,022)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Quality Improvement Ethics: Lessons From the SUPPORT Study.Benjamin S. Wilfond - 2013 - American Journal of Bioethics 13 (12):14-19.
Nanomedicine First-in-Human Research: Challenges for Informed Consent.Nancy M. P. King - 2012 - Journal of Law, Medicine and Ethics 40 (4):823-830.

View all 10 citations / Add more citations

References found in this work

No references found.

Add more references